Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 2Withdrawn 1Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 10Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Neoplasm Metastasis 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1SCLC,Extensive Stage 1Rare Tumor 1Penile Neoplasms 1Pathologic Complete Response 1Pancreatic Adenocarcinoma Metastatic 1Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1Ovarian Carcinosarcoma 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Hemangiosarcoma 1Glioblastoma 1Endometrial Neoplasms 1Cystadenocarcinoma, Serous 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Biliary Tract Neoplasms 1Advanced Solid Tumor 1

Interventions

Temozolomide 45Radiotherapy 17Magnetic Resonance Spectroscopy 17Specimen Handling 14Bevacizumab 12pembrolizumab 11Lomustine 9Radiation 8fludarabine 7Cyclophosphamide 7atezolizumab 4Biopsy 4olaparib 3Transurethral Resection of Bladder 3Surgical Procedures, Operative 3Nivolumab 3Leukapheresis 3D2C7-(scdsFv)-PE38KDEL 3Blood Specimen Collection 3Aminolevulinic Acid 3regorafenib 2fluciclovine F-18 2contrast agent BR1 2antisecretory factor 2abemaciclib 2Restraint, Physical 2Re-Irradiation 2Radiation Dose Hypofractionation 2Palliative Care 2Oncolytic Virotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Glioblastoma × niraparib × Clear all
NCT06388733 2026-04-01

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

NeuroTrials, LLC

Phase 3 Recruiting
450 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡